Skip to main content
Clinical Trials/NCT06381063
NCT06381063
Recruiting
Phase 3

Effect of Non-steroidal Anti-inflammatory Drugs in Pain Management After Cardiac Surgery

Centre Hospitalier Universitaire, Amiens1 site in 1 country238 target enrollmentMarch 27, 2024

Overview

Phase
Phase 3
Intervention
pain management
Conditions
Acute Postoperative Pain
Sponsor
Centre Hospitalier Universitaire, Amiens
Enrollment
238
Locations
1
Primary Endpoint
NSAIDs reduce postoperative at rest at 24 hours from the end of surgery
Status
Recruiting
Last Updated
9 months ago

Overview

Brief Summary

Non-steroidal anti-inflammatory drugs (NSAID) are part the multimodal strategy in pain management after surgery. However, major concerns are raised in cardiac surgery given the potential side effects of NSAID with more bleeding and acute kidney injury. The investigators hypothesized that NSAID are safe in the early postoperative course after cardiac surgery with respect to contraindication.

Registry
clinicaltrials.gov
Start Date
March 27, 2024
End Date
July 1, 2027
Last Updated
9 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • scheduled for cardiac surgery (aortic valve replacement, coronary artery bypass graft, mitral valve repair or replacement, intracardiac tumor, aortic root repair)
  • under cardiopulmonary bypass
  • Affiliation to the French national healthcare system
  • Written consent obtained

Exclusion Criteria

  • weight\<50 kg
  • chronic use of NSAID
  • mini-invasive surgery
  • NSAID contraindication
  • NSAID allergy
  • Nefopam contraindication
  • Paracetamol contraindication
  • Tramadol contraindication
  • Urgent surgery
  • Endocarditis

Arms & Interventions

Ketoprofen

Ketoprofen 100 mg twice a day, during 48 after surgery, intravenous administration

Intervention: pain management

Ketoprofen

Ketoprofen 100 mg twice a day, during 48 after surgery, intravenous administration

Intervention: ketoprofen

Placebo

Placebo twice a day, during 48 h after surgery, intravenous administration

Intervention: pain management

Placebo

Placebo twice a day, during 48 h after surgery, intravenous administration

Intervention: PLacebo

Outcomes

Primary Outcomes

NSAIDs reduce postoperative at rest at 24 hours from the end of surgery

Time Frame: at 24 hours

Pain intensity will be assessed at rest at 24 hours from the end surgery using the numerous rating scale (NRS) graded from 1 (no pain) to 10 (high pain intensity)

reduction in pain intensity during chest physiotherapy at 24 hours from the end of surgery

Time Frame: at 24 hours

Pain intensity will be assessed using the NRS at 24 hours from the end of surgery during chest physiotherapy

Secondary Outcomes

  • Change in pain trajectory during the first 7 days after cardiac surgery(7 days)
  • Change in cumulative opioid within 48 hours after surgery(48 hours)
  • Change in pulmonary postoperative complications within 7 days after surgery(7 days)

Study Sites (1)

Loading locations...

Similar Trials